Direct Buyers Fight GSK, Teva's Bid To Stay Lamictal Suit
Drug wholesalers urged a New Jersey federal court Monday to nix a bid from GlaxoSmithKline PLC and Teva Pharmaceutical Industries Ltd. to pause an antitrust suit over the availability of generic...To view the full article, register now.
Already a subscriber? Click here to view full article